← FDA DRUG APPROVALS
FDA ANDA · ANDA215791
DEGARELIX ACETATE
Sponsor: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
APPLICATION
ANDA215791
TYPE
ANDA
DOSAGE FORM
NJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING STATUS
None (Tentative Approval)
Products
DEGARELIX ACETATENone (Tentative Approval)
DEGARELIX ACETATE 80MG · NJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Approval history
2025-08-18UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.